Fenbendazole and Ivermectin in Cancer Care: What the Research Actually Shows

A clinical nutritionist's review of mechanisms — including p53 reactivation, microtubule disruption, glycolysis inhibition, and immune synergy — for two of the most-discussed repurposed antiparasitics in integrative oncology.

Researched and written by Keith Bishop, Integrative Cancer Educator, Cancer Coach, Clinical Nutritionist, Retired Pharmacist, and Founder of Prevail Over Cancer.

You've heard the names. A friend mentioned them. A YouTube video swore by them. A Facebook group of 100,000 members says they cured stage IV cancer. And your oncologist either rolled their eyes or warned you against them.

So what is actually true about fenbendazole and ivermectin in cancer care?

After three decades as a pharmacist and now as a clinical nutritionist and cancer coach working with patients every day, I want to walk you through what the published research actually shows — the mechanisms, the preclinical data, th...

Breaking Ground in Cancer Research: Ivermectin Cancer Potential Revealed!

Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Retired Pharmacist

Notice: This information is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with your healthcare team before considering the integration of ivermectin or any other therapy into your health program to ensure it aligns with your specific medical needs and circumstances.

Ivermectin History

Ivermectin is a medication primarily used to treat parasitic infections. It was initially developed in the 1970s for veterinary use but was later approved for human use in the 1980s. In humans, ivermectin is prescribed for conditions such as strongyloidiasis (intestinal infection caused by threadworms) and onchocerciasis (river blindness). It is also used topically to treat head lice and skin conditions like rosacea.

Ivermectin An...